Evidence map›Paper›PMID 39798052›Full record

ArticleApplied biochemistry and biotechnology2025

In Vitro Cytotoxic Potential and Integrated Network Pharmacology, Molecular Docking and Molecular Dynamic Approaches to Decipher the Mechanism of Gymnostachyum febrifugum Benth., in the Treatment of Breast Cancer.

K J Spandana, Wilson Joel Rodrigues, Sudeep D Ghate, R Shyama Prasad Rao, K R Chandrashekar, N Bhagya

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

K J SpandanaYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, 575018, Karnataka, India.
Wilson Joel RodriguesJSS Academy of Higher Education and Research, (Deemed to be University), Shivarathreeshwara Nagara, Mysuru, 570015, Karnataka, India.
Sudeep D GhateCentral Research Laboratory, NITTE (Deemed to be University), K.S. Hegde Medical Academy, Mangalore, 575018, India.
R Shyama Prasad RaoCentral Research Laboratory, NITTE (Deemed to be University), K.S. Hegde Medical Academy, Mangalore, 575018, India.
K R ChandrashekarYenepoya Pharmacy and Ayush Research Centre (YEN PARC), Yenepoya (Deemed to be University), Deralakatte, Mangalore, Karnataka, 575018, India.
N BhagyaYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, 575018, Karnataka, India. bhagya163@gmail.com.ORCID http://orcid.org/0000-0001-6732-5772

Funding

Yenepoya University No. YU/Seed grant/097-2021
6 · The paper itself

Abstract

Gymnostachyum febrifugum, a less-known ethnomedicinal plant from the Western Ghats of India, is used to treat various diseases and serves as an antioxidant and antibacterial herb. The present study aims to profile the cytotoxic phytochemicals in G. febrifugum roots using GC-MS/MS, in vitro confirmation of cytotoxic potential against breast cancer and an in silico study to understand the mechanism of action. Phytochemical profiling using GC-MS/MS showed the presence of eight cytotoxic molecules with lupeol in high abundance. A potent cytotoxic effect of G. febrifugum roots against breast cancer was also observed with antiproliferation, antimigration, inhibition in colony formation and death of breast cancer cells. Further, the cytotoxic potential of the plant was confirmed with the apoptosis of cells as observed in the flow cytometry. In silico network pharmacology, GO and KEGG analysis suggested the modulation of proteins of MAPK, PI3K-AKT and apoptosis pathways by lupeol to induce cytotoxicity in breast cancer. Further, dynamic simulation revealed MAPK and AKT as the major targets for lupeol. Our studies comprehensively elucidated the role of lupeol, a major phytochemical in G. febrifugum to induce cytotoxicity against breast cancer by targeting major cancer signaling pathways, providing a promising strategy and scientific basis to explore lupeol in targeted cancer therapy.

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologyPlant ExtractsApoptosisCell Line, TumorCell ProliferationFemaleHumansLupanesMCF-7 CellsPentacyclic TriterpenesAntineoplastic Agents, PhytogenicLupaneslupeolPentacyclic TriterpenesPlant ExtractsApoptosisCytotoxicityGC–MS/MSGymnostachyum febrifugumMD simulationMolecular dockingNetwork pharmacology

Identifiers

PMID39798052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.